C. Brambilla

发表

p14ARF Triggers G2 Arrest Through ERK-Mediated Cdc25C Phosphorylation, Ubiquitination and Proteasomal Degradation

E. Brambilla, P. Claverie, B. Eymin, 2006, Cell cycle.

The Human pl9ARF Protein Encoded by the ÃŸTranscript of the pl6INK4a Gene Is Frequently Lost in Small Cell Lung Cancer1

E. Brambilla, C. Larsen, C. Brambilla, 2006 .

Early detection of lung cancer: role of biomarkers

S. Lantuejoul, G. Ferretti, S. Lantuejoul, 2003, European Respiratory Journal.

Alterations of expression of Rb, p16INK4A and cyclin D1 in non‐small cell lung carcinoma and their clinical significance

E. Brambilla, C. Brambilla, S. Gazzéri, 1999, The Journal of pathology.

The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer.

E. Brambilla, V. D. Valle, C. Larsen, 1998, Cancer research.

Systems medicine and integrated care to combat chronic noncommunicable diseases

L. Hood, C. Auffray, A. Ballabio, 2011, Genome Medicine.

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

Masahiro Tsuboi, Iver Petersen, Hisao Asamura, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

K. Cibulskis, J. Shendure, G. Getz, 2012, Nature Genetics.

A Genomics-Based Classification of Human Lung Tumors

G. Getz, S. Carter, D. Hayes, 2013, Science Translational Medicine.

Accuracy of oximetry for detection of respiratory disturbances in sleep apnea syndrome.

C. Brambilla, J. Pépin, P. Lévy, 1996, Chest.

Does oximetry contribute to the detection of apneic events? Mathematical processing of the SaO2 signal.

C. Guilleminault, P. Lévy, C. Brambilla, 1991, Chest.

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

I. Petersen, R. Beroukhim, H. Groen, 2010, Science Translational Medicine.

Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers

Elisabeth Brambilla, Sophie Rousseaux, Aurélien de Reyniès, 2013, Science Translational Medicine.

E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35

L. Corcos, E. Brambilla, A. V. Broeck, 2008, Cell Death and Differentiation.

E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors

E. Brambilla, B. Eymin, C. Salon, 2007, Oncogene.

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors

Paul J. Friedman, Anders Eklund, Nestor L. Müller, 2002, American journal of respiratory and critical care medicine.

Central airway stenoses: preliminary results of spiral-CT-generated virtual bronchoscopy simulations in 29 patients

G. R. Ferretti, I. Bricault, J. Knoplioch, 1997, European Radiology.

Human ARF binds E2F1 and inhibits its transcriptional activity

E. Brambilla, C. Larsen, B. Eymin, 2001, Oncogene.

Expression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1 [Flt-1] and VEGF-R2 [KDR/Flk-1]) in tumorlets and in neuroendocrine cell hyperplasia of the lung.

E. Brambilla, C. Brambilla, P. Brichon, 2004, Human pathology.

Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?

E. Brambilla, C. Brambilla, F. de Fraipont, 2005, Lung cancer.

Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis.

E. Brambilla, C. Brambilla, J. Coll, 1998, Human gene therapy.

Long-term oxygen therapy at home. Compliance with medical prescription and effective use of therapy. ANTADIR Working Group on Oxygen Therapy. Association Nationale de Traitement à Domicile des Insuffisants Respiratories.

J. Pépin, C. Brambilla, C. Deschaux, 1996, Chest.

Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing

G. Ferretti, E. Brambilla, S. Lantuejoul, 2004, European Respiratory Journal.

Lung tumors : fundamental biology and clinical management

E. Brambilla, C. Brambilla, 1998 .

[Endoluminal 3D reconstruction of the tracheo-bronchial tree (virtual bronchoscopy)].

P. Cinquin, G. Ferretti, J. Knoplioch, 1995, Journal de radiologie.

The E-cadherin–β-catenin complex and its implication in lung cancer progression and prognosis

E. Brambilla, S. Lantuejoul, B. Eymin, 2005 .

Stability of the Phenotypic Characters

E. Brambilla, C. Brambilla, P. Brichon, 1989 .

Heterotraxsnsplantation of small cell lung carcinoma into nude mice. Stability of the phenotypic characters

E. Brambilla, C. Brambilla, P. Brichon, 1989 .

Combination of 5-FU cisplatinum and hypofractionated irradiation followed by split-course radiotherapy in 47 patients with unresectable non small cell lung cancer.

M. Bolla, C. Brambilla, D. Moro, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.

V. Gouyer, E. Brambilla, C. Brambilla, 1998, American journal of respiratory cell and molecular biology.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1996, The American journal of pathology.

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours

E. Brambilla, S. Lantuejoul, J. Soria, 2004, British Journal of Cancer.

Progressive lung cancer determined by expression profiling and transcriptional regulation.

A. Brass, E. Brambilla, A. Risch, 2012, International journal of oncology.

Primary lung adenocarcinoma: characteristics by smoking habit and sex

E. Brambilla, S. Lantuejoul, J. Timsit, 2011, European Respiratory Journal.

VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

E. Brambilla, B. Eymin, C. Brambilla, 2018, Oncogene.

Receptor-Independent Ectopic Activity of Prolactin Predicts Aggressive Lung Tumors and Indicates HDACi-Based Therapeutic Strategies.

E. Brambilla, C. Brambilla, Minoru Yoshida, 2015, Antioxidants & redox signaling.

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Antoine Flahault, Catherine Beigelman-Aubry, Yves Martinet, 2007, Lung cancer.

Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.

E. Brambilla, S. Lantuejoul, M. Papotti, 2002, Human pathology.

Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.

E. Brambilla, S. Lantuejoul, M. Papotti, 2001, Human pathology.

Immunohistochemical study of p53 in human lung carcinomas.

V. Gouyer, E. Brambilla, C. Caron de Fromentel, 1993, The American journal of pathology.

34βE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma

E. Brambilla, S. Lantuejoul, M. Papotti, 2003 .

Neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes.

E. Brambilla, C. Brambilla, D. Moro, 1992, American journal of clinical pathology.

CT-guided Biopsy of Nonresolving Focal Air Space Consolidation

G. Ferretti, S. Lantuejoul, C. Brambilla, 2008, Journal of thoracic imaging.

Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.

G. Ferretti, E. Brambilla, C. Brambilla, 1994, European journal of cancer.

WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway.

C. Harris, E. Brambilla, M. Serrano, 2009, Cancer research.

Is a New Marker of Cellular Senescence That Regulates p 53 Activity and the Phosphoinositide 3-Kinase / AKT Pathway

C. Harris, E. Brambilla, M. Serrano, 2009 .

Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice.

A. Benabid, E. Brambilla, C. Brambilla, 1991, Cancer research.

E-cadherin-β-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis

E. Brambilla, S. Lantuejoul, H. Drabkin, 2004 .

Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study

Mickael Guedj, Elisabeth Brambilla, David G. Beer, 2010, PloS one.

Mechanisms of p16INK4A inactivation in non small-cell lung cancers

V. Gouyer, E. Brambilla, C. Brambilla, 1998, Oncogene.

34BetaE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma.

E. Brambilla, S. Lantuejoul, M. Papotti, 2003, Histopathology.

Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF‐R1‐Flt1 and VEGF‐R2‐Flk1/KDR) in non‐small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival

E. Brambilla, C. Brambilla, D. Moro, 1999, The Journal of pathology.

Mutant Immunophenotype and Deregulation of p 53 Transcription Pathway ( Bc 12 , Bax , and Waft ) in Precursor Bronchial Lesions of Lung Cancer 1

E. Brambilla, S. Lantuejoul, C. Brambilla, 2005 .

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

Martin Vingron, Thomas Zander, Yupeng Cun, 2018, Nature Communications.

Molecular Biomarkers Workshop: a European Strategy for Developing Lung Cancer Molecular Diagnostics in High Risk Populations

F. Hirsch, J. Mulshine, T. Sutedja, 2001 .

Basaloid bronchial carcinoma. A histologic group with a poor prognosis

E. Brambilla, C. Brambilla, P. Brichon, 1994, Cancer.

CT characteristics of resolving ground-glass opacities in a lung cancer screening programme.

G. Ferretti, S. Lantuejoul, J. Timsit, 2011, European journal of radiology.

[Non-solid and part-solid pulmonary nodules on CT scanning].

G. Ferretti, S. Lantuejoul, C. Brambilla, 2007, Revue des maladies respiratoires.

p53 genetic abnormalities and myc activation in human lung carcinoma

F. Berger, V. Gouyer, E. Brambilla, 1994, International journal of cancer.

Amplification of oncogenes in lung carcinoma grafted in nude mice.

A. Benabid, E. Brambilla, C. Brambilla, 1989, Anticancer research.

Abstract 1531: Cross-entity mutation analysis of lung neuroendocrine tumors sheds light into their molecular origin and identifies new therapeutic targets

Roman K. Thomas, T. Zander, E. Brambilla, 2014 .

Formoterol 12 μg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol: A multicenter, randomized, open-label, parallel-group study

C. Brambilla, I. Bourdeix, V. L. Gros, 2003 .

Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.

E. Brambilla, C. Brambilla, D. Moro, 1996, Laboratory investigation; a journal of technical methods and pathology.

Erdheim-Chester disease: a primary macrophage cell disorder.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1998, American journal of respiratory and critical care medicine.

Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma.

E. Brambilla, C. Brambilla, P. Brichon, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salmeterol compared with slow‐release terbutaline in nocturnal asthma A multicenter, randomized, double‐blind, double‐dummy, sequential clinical trial

C. Chastang, C. Brambilla, L. Bertin, 1994, Allergy.

A 3-Month Comparative Dose-Reduction Study with Inhaled Beclomethasone Dipropionate and Budesonide in the Management of Moderate to Severe Adult Asthma

C. Brambilla, P. Godard, P. Duroux, 1994 .

Alveolar neutrophilia is a predictor for the bronchiolitis obliterans syndrome, and increases with degree of severity.

E. Brambilla, I. Pin, C. Brambilla, 2002, Transplant immunology.

Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study.

P. Braquet, C. Brambilla, B. Bonvoisin, 1987, Prostaglandins.

Statin-induced fibrotic nonspecific interstitial pneumonia

E. Brambilla, S. Lantuejoul, C. Brambilla, 2002, European Respiratory Journal.

Isoenzyme pattern of enolase in the diagnosis of neuroendocrine bronchopulmonary tumors

E. Brambilla, C. Brambilla, F. Morel, 1987, Cancer.

[Multiple congenital stenoses of the segmental pulmonary arteries in an elderly patient].

G. Ferretti, C. Brambilla, G. Devouassoux, 2003, Revue de Pneumologie Clinique.

Early lung leukocyte infiltration, HLA and adhesion molecule expression predict chronic rejection.

E. Brambilla, I. Pin, C. Brambilla, 2001, Transplant immunology.

Clinical prognostic indicators of high-grade pre-invasive bronchial lesions

E. Brambilla, S. Lantuejoul, C. Brambilla, 2004, European Respiratory Journal.

Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels.

E. Brambilla, S. Lantuejoul, B. Eymin, 2007, The Journal of pathology.

[Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases].

C. Brambilla, J. Guerin, C. Boutin, 1993, Revue de pneumologie clinique.

Portable oxygen therapy: use and benefit in hypoxaemic COPD patients on long-term oxygen therapy.

C. Brambilla, J Vergeret, C Brambilla, 1989, The European respiratory journal.

Interference with netrin-1 and tumor cell death in non-small cell lung cancer.

E. Brambilla, V. Firlej, P. Mehlen, 2009, Journal of the National Cancer Institute.

Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.

E. Brambilla, C. Verri, D. Conte, 2009, American journal of respiratory and critical care medicine.

Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis.

C. Brambilla, H. Staley, B. Clecner, 1998, International journal of clinical practice.

Comparison of two oral antibiotics, roxithromycin and amoxicillin plus clavulanic acid, in lower respiratory tract infections.

B. Dautzenberg, E. Lemarié, C. Brambilla, 1992, Diagnostic microbiology and infectious disease.

Comparative pathology of silicate pneumoconiosis.

K. Benirschke, E. Brambilla, C. Brambilla, 1979, The American journal of pathology.

E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c- FLIP short Running title: E2F1 targets c-FLIP S to induce apoptosis

E. Brambilla, B. Eymin, C. Salon, 2020 .

Lobular distributed ground-glass opacification due to metastatic cardiac angiosarcoma: High resolution CT, MIP, and pathologic findings

G. Ferretti, S. Lantuejoul, C. Brambilla, 2007 .

TUNEL: Improvement and Evaluation of the Method for In Situ Apoptotic Cell Identification

E. Brambilla, C. Guillermet, C. Brambilla, 1997 .

Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.

E. Brambilla, C. Brambilla, D. Moro, 1997, The American journal of pathology.

[Suspected pulmonary embolism. Concept of care to be given].

C. Brambilla, M. Coulomb, B. Paramelle, 1981, La Nouvelle presse medicale.

Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma

G. Ferretti, E. Brambilla, S. Lantuejoul, 2007, European Respiratory Journal.

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

C. Brambilla, J. Edelson, G. Schultze-Werninghaus, 2001, The Lancet.

Pulmonary infarction revealing pulmonary Takayasu's arteritis.

C. Brambilla, C. Pison, M. Coulomb, 1998, Respiratory medicine.

Mucinous cystadenoma of the lung

E. Brambilla, S. Lantuejoul, C. Brambilla, 1995, Cancer.

[Pleural granulocytic sarcoma. Apropos of a case and review of the literature].

E. Brambilla, S. Lantuejoul, C. Brambilla, 1998, Revue des maladies respiratoires.

NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas.

E. Brambilla, S. Lantuejoul, C. Brambilla, 2000, Human pathology.

Endovascular treatment of superior vena cava obstruction in patients with malignancies

G. Ferretti, F. Thony, C. Brambilla, 1999, European Radiology.

Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors.

E. Brambilla, S. Lantuejoul, R. Michalides, 1998, The American journal of surgical pathology.

Use of Guthrie cards for the early diagnosis of neonatal herpes simplex virus disease.

M. Barbi, C. Brambilla, V. Primache, 1998, The Pediatric infectious disease journal.

In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations.

E. Brambilla, C. Guillermet, C. Brambilla, 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

CEA, CYFRA21-1 and SCC in non-small cell lung cancer.

C. Brambilla, D. Moro, J P Vuillez, 1995, Lung cancer.

p53 and lung cancer.

E. Brambilla, C. Brambilla, 1997, Pathologie-biologie.

Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin

E. Brambilla, B. Eymin, C. Brambilla, 2011, The EMBO journal.

Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer

E. Brambilla, S. Lantuejoul, C. Brambilla, 2005, European Respiratory Journal.

CD74-NRG1 fusions in lung adenocarcinoma.

I. Petersen, S. Haas, M. Vingron, 2014, Cancer discovery.

Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Alterations of Rb Pathway ( Rbp 16 INK 4-Cyclin D 1 ) in Preinvasive Bronchial Lesions 1

E. Brambilla, S. Lantuejoul, C. Brambilla, 1999 .

p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Distinct pancreatic and neuronal Lung Carcinoid molecular subtypes revealed by integrative omic analysis

M. Lathrop, M. Moffatt, C. Brambilla, 2021, medRxiv.

Sumoylation of ING2 regulates the transcription mediated by Sin3A

C. Brambilla, D. Larrieu, R. Pedeux, 2010, Oncogene.

E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIPshort

E. Brambilla, B. Eymin, C. Salon, 2006, Cell Death and Differentiation.

Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma

E. Brambilla, C. Brambilla, S. Veyrenc, 2003, The Journal of pathology.

Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort

M. Olivier, P. Hainaut, E. Brambilla, 2012, European Respiratory Journal.

Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors

E. Brambilla, B. Eymin, C. Brambilla, 2002, Oncogene.

Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.

A. Benabid, E. Brambilla, C. Brambilla, 1990, Cancer research.

Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.

C. Meijer, P. Snijders, E. Smit, 2010, International journal of oncology.

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

I. Petersen, D. Hayes, M. Wilkerson, 2018, Nature Communications.

Biology of Human Tumors Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Speci fi c Molecular Entity

P. Hainaut, E. Brambilla, S. Lantuejoul, 2014 .

Cooperation of Amphiregulin and Insulin-like Growth Factor-1 Inhibits Bax- and Bad-mediated Apoptosis via a Protein Kinase C-dependent Pathway in Non-small Cell Lung Cancer Cells*

P. Auberger, B. Mari, C. Brambilla, 2005, Journal of Biological Chemistry.

Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma

E. Brambilla, B. Eymin, C. Brambilla, 2001, Oncogene.

ING2 controls the G1 to S-phase transition by regulating p21 expression

C. Brambilla, D. Larrieu, R. Pedeux, 2010, Cell cycle.

Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.

E. Brambilla, S. Lantuejoul, C. Brambilla, 2010, Lung cancer.

ING2 controls the progression of DNA replication forks to maintain genome stability

E. Brambilla, S. Sengupta, C. Brambilla, 2009, EMBO reports.

The new tumor suppressor genes ING: Genomic structure and status in cancer

E. Brambilla, C. Brambilla, D. Larrieu, 2008, International journal of cancer.

Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.

V. Gouyer, E. Brambilla, B. Vandenbunder, 1995, The American journal of pathology.

Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study).

N. Girard, E. Brambilla, J. Timsit, 2014, Lung cancer.

Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.

M. Meyerson, I. Petersen, R. Onofrio, 2011, Cancer discovery.

in squamous cell lung cancer

M. Meyerson, I. Petersen, R. Onofrio, 2011 .

Mutations in the DDR 2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer

M. Meyerson, I. Petersen, R. Onofrio, 2011 .

Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer

M. Olivier, P. Brennan, V. Gaborieau, 2016, EBioMedicine.

Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.

Elisabeth Brambilla, Stéphane Vignot, Roman Yelensky, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.

I. Wistuba, E. Brambilla, C. Behrens, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification

J. Austin, A. Nicholson, I. Petersen, 2009 .

Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression.

E. Brambilla, C. Brambilla, I. Bolon, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[Acute eosinophilic pneumonia and the larva migrans syndrome: apropos of a case in an adult].

C. Brambilla, B. Paramelle, F. Arbib, 1994, Revue des maladies respiratoires.

[Early diagnosis of bronchial carcinoma after head and neck cancer].

G. Ferretti, C. Brambilla, D. Moro-Sibilot, 2008, Revue des maladies respiratoires.

Pulmonary Nodules with the CT Halo Sign

S. Lantuejoul, C. Brambilla, M. Coulomb, 2002, Respiration.

Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections

C. Brambilla, S. Knight, S. Kastanakis, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[Excision by video-thoracoscopy of a mediastinal bronchogenic cyst. A case report].

E. Brambilla, C. Brambilla, P. Brichon, 1993, Revue des maladies respiratoires.

Pulmonary Pathology of Erdheim-Chester Disease

F. Galateau-Sallé, W. Travis, E. Brambilla, 2000, Modern Pathology.

Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance.

E. Brambilla, C. Brambilla, P. Brichon, 1992, Human pathology.

Telomere Shortening and Telomerase Reverse Transcriptase Expression in Preinvasive Bronchial Lesions

E. Brambilla, S. Lantuejoul, J. Soria, 2005, Clinical Cancer Research.

The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

E. Brambilla, B. Eymin, C. Brambilla, 2010, Oncogene.

Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.

E. Brambilla, S. Lantuejoul, C. Brambilla, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Telomere Maintenance and DNA Damage Responses during Lung Carcinogenesis

E. Brambilla, S. Lantuejoul, J. Soria, 2010, Clinical Cancer Research.

Clinical value of an amplified electrophoretic determination of enolase isoenzymes in small cell lung carcinoma patients.

E. Brambilla, C. Brambilla, B. Paramelle, 1989, Scandinavian journal of clinical and laboratory investigation.

Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer

E. Brambilla, S. Lantuejoul, B. Eymin, 2008, Clinical Cancer Research.

Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers

E. Brambilla, P. Barbry, C. Brambilla, 2010, Oncogene.

Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis

E. Brambilla, S. Lantuejoul, J. Timsit, 2008, European Respiratory Journal.

Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro‐endocrine lung carcinomas

A. Benabid, V. Gouyer, E. Brambilla, 1994, International journal of cancer.

SRSF2 is required for sodium butyrate-mediated p21WAF1 induction and premature senescence in human lung carcinoma cell lines

E. Brambilla, B. Eymin, C. Brambilla, 2011, Cell cycle.

Editor's Note: Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer

E. Brambilla, S. Lantuejoul, B. Eymin, 2020, Clinical Cancer Research.

Bronchorrhea revealing cervix adenocarcinoma metastastic to the lung.

C. Brambilla, D. Moro, G. Devouassoux, 2001, Lung cancer.

[Pulmonary inflammatory pseudotumor complicating the course of a community-acquired pneumopathy. A deceptive radio-clinical presentation].

E. Brambilla, S. Lantuejoul, C. Brambilla, 1997, Revue des maladies respiratoires.

A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients

C. Aspord, E. Brambilla, C. Brambilla, 2023, International journal of molecular sciences.

Chemical constituents of diesel exhaust particles induce IL-4 production and histamine release by human basophils.

A. Saxon, C. Brambilla, D. Metcalfe, 2002, The Journal of allergy and clinical immunology.

Infection respiratoire et cancer bronchique

C. Brambilla, D. Moro, P. Romand, 1992 .

Idiopathic pulmonary hemorrhage. Ultrastructural and mineralogic study.

C. Brambilla, P. Stoebner, E. Brambilla, 1982, Chest.

Cannabis: the next villain on the lung cancer battlefield?

C. Brambilla, M. Colonna, 2008, European Respiratory Journal.

Major conceptual change required to improve lung cancer: see a respiratory physician

C. Brambilla, J. Field, 2003, European Respiratory Journal.

Long-term Oxygen Therapy at Home: Compliance With Medical Prescription and Effective Use of Therapy

Jean-Louis Pépin, J. Pépin, C. Brambilla, 1996 .

Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: results from a multi-centre case-control study in Europe.

Xifeng Wu, J. Timsit, A. Cassidy, 2009, European journal of cancer.

EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration

Y. Martinet, P. Hainaut, E. Brambilla, 2009, European Respiratory Journal.

Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study

N. Girard, G. Ferretti, E. Brambilla, 2014, BMC Cancer.

Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: a retrospective study of 300 patients.

E. Brambilla, J. Timsit, C. Brambilla, 2012, Lung cancer.

From surgical to molecular scalpel: ERJ lung cancer series for 2009

C. Brambilla, 2009, European Respiratory Journal.

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer

J. Zavadil, M. Olivier, S. Villar, 2015, European Respiratory Journal.

Cigarette smoking, preinvasive bronchial lesions, and autofluorescence bronchoscopy.

E. Brambilla, S. Lantuejoul, C. Brambilla, 2002, Chest.

Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development.

F. Thunnissen, C. Brambilla, L. Montuenga, 2012, Lung cancer.

moking history and lung carcinoma : KRAS mutation is an early hit in lung denocarcinoma development

C. Brambilla, B. Thunnissena, C. Prinsenb, 2011 .

Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines

Elisabeth Brambilla, E. Brambilla, S. Lantuejoul, 2003, The Journal of pathology.

Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.

R. Mirimanoff, M. Bolla, R. Miralbell, 1998, International journal of radiation oncology, biology, physics.

[Agreement between clinical practice guidelines for management of community-acquired pneumonia. A retrospective study of 101 hospitalized patients].

C. Brambilla, J. Labarère, P. François, 2003, Revue des maladies respiratoires.

Evaluation of survival and prognostic factors in 2,000 broncho-pulmonary cancers registered during 10 years in an oncology department

M. Bolla, C. Brambilla, P. Brichon, 1997 .

Sequential combination of 5-fluorouracil, cis-platinum and irradiation in unresectable non-small cell lung cancer.

M. Bolla, B. Wuyam, C. Brambilla, 1989, Radiotherapy and Oncology.

[Pneumoconiosis due to amorphous silica smoke. Mineralogical and ultrastructural study of 6 cases (author's transl)].

E. Brambilla, C. Brambilla, B. Paramelle, 1980, Revue francaise des maladies respiratoires.

Effects of captopril combined with oxygen therapy at rest and on exercise in patients with chronic bronchitis and pulmonary hypertension.

C. Brambilla, C. Pison, J. Wolf, 1991, Respiration; international review of thoracic diseases.

[Immunotherapy of cancer using cytokinins. Use and perspectives in lung oncology].

C. Brambilla, D. Moro, A. Goy, 1990, Revue des maladies respiratoires.

Nonsolid and part-solid pulmonary nodules

G. Ferretti, S. Lantuejoul, C. Brambilla, 2009 .

[Incidence of polyneuropathies in chronic obstructive bronchopneumopathies].

C. Brambilla, P. Stoebner, B. Paramelle, 1986, Presse medicale.

Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors

C. Brambilla, F. Paganin, H. Portier, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Impact of Molecular Pathology on the Clinical Management of Lung Cancer

E. Brambilla, S. Lantuejoul, C. Brambilla, 2005, Respiration.

Photodynamic therapy: where do we go from here?

C. Brambilla, D. Moro-Sibilot, 2003, European Respiratory Journal.

Pulmonary histiocytosis X with mediastinal lymph node involvement.

E. Brambilla, C. Brambilla, C. Pison, 1990, The American review of respiratory disease.

Pleural Immunocytoma with Waldenström’s Macroglobulinemia

E. Brambilla, C. Brambilla, P. Stoebner, 1981 .

Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations.

M. Spitz, A. Flahault, I. Wistuba, 2002, International journal of oncology.

Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.

E. Brambilla, C. Brambilla, P. Brichon, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity

P. Hainaut, E. Brambilla, S. Lantuejoul, 2014, Clinical Cancer Research.

Translational Relevance

Sophie, Saadi, P. Hainaut, 2022 .

[How do we reduce the under-reporting of occupational primary lung cancer].

C. Brambilla, A. Perdrix, A. Maître, 2002, Revue des maladies respiratoires.

Somnofluoroscopy, computed tomography, and cephalometry in the assessment of the airway in obstructive sleep apnoea.

G. Ferretti, C. Brambilla, M. Coulomb, 1992, Thorax.

E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis.

E. Brambilla, S. Lantuejoul, H. Drabkin, 2004, Human pathology.

[Can oximetry contribute to the detection of apnea? The use of a mathematical analysis of the oximetry signal].

B. Wuyam, P. Lévy, C. Brambilla, 1990, Revue des maladies respiratoires.

[Recurrent lung disease in a baker].

C. Brambilla, M. Jeanmart, F. Arbib, 1999, Revue des maladies respiratoires.

Isoenzyme pattern of enolase and creatine kinase in small cell lung cancer patients.

E. Brambilla, C. Brambilla, H. Nagy, 1987, Chest.

VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a 1 integrin/VEGFR autocrine loop

E. Brambilla, C. Brambilla, J. Coll, 2020 .

Chest pains complicating an artificial therapeutic pneumothorax.

E. Brambilla, S. Lantuejoul, C. Brambilla, 1997, European Respiratory Journal.

[Hydropneumothorax of an unusual cause].

C. Brambilla, P. Brichon, C. Pison, 1989, Revue des maladies respiratoires.

Highlights in lung cancer.

C. Brambilla, S. Spiro, 2001, The European respiratory journal.

Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.

E. Brambilla, S. Lantuejoul, B. Vandenbunder, 1996, Laboratory investigation; a journal of technical methods and pathology.

Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection

A. Jankowski, M. Coulomb, G. Ferretti, 2007, European Radiology.

Assessment of the severity of asthma by an expert system. Description and evaluation.

B Wallaert, J Marsac, C. Brambilla, 1995, American journal of respiratory and critical care medicine.

[Bronchiolitis obliterans with idiopathic organized pneumonia. Anatomoclinical analysis and nosologic discussion apropos of 6 cases].

E. Brambilla, C. Brambilla, C. Pison, 1990, Annales de medecine interne.

Phase II trial of vindesine in malignant pleural mesothelioma.

C. Brambilla, B. Paramelle, J. Guerin, 1987, Cancer treatment reports.

Concordance of driver mutations in primary and matched metastasis from patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS).

P. Stephens, R. Yelensky, M. Cronin, 2012 .

Double-blind placebo-controlled trial of baclofen, alone and in combination, in patients undergoing voluntary abortion.

C. Brambilla, O. Corli, M. Bacchini, 1984, Clinical therapeutics.

American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

I. D. Johnston, R. Hubbard, D. Lynch, 2002 .

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

J. Austin, I. Petersen, V. Rusch, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

I. Petersen, R. Beroukhim, H. Groen, 2010, Science Translational Medicine.

[Development of nocturnal desaturation in 35 patients with chronic obstructive bronchopneumopathy (COBP). Relation to functional and hemodynamic data].

P. Lévy, C. Brambilla, B. Paramelle, 1989, Revue des maladies respiratoires.

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.

I. Wistuba, E. Brambilla, C. Behrens, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.